drugset / Trial / NCT01067781

Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch

NCT01067781 ↗

Phase 2 Completed 600 enrolled Intercell USA, Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate and compare the safety and immune responses following a two vaccination regimen by transcutaneous immunization with heat-labile enterotoxin of E. coli (LT) patches or Placebo, with or without alcohol swabbing

Timeline

Start
2010-02
Primary completion
2010-09
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject heat-labile enterotoxin of E. coli (LT) Vaccine — Other

Indications